Inactive Instrument

Highlights Apollo Endosurgery, Inc.

Equities

APEN

US03767D1081

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Boston Scientific Corporation completed the acquisition of Apollo Endosurgery, Inc. from a group of shareholders.	23-04-03	CI
North American Morning Briefing : Futures Dip As a -2-	23-01-05	DJ
Apollo Endosurgery : Merger Agreement - Form 8-K	22-12-28	PU
Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal	22-11-29	DJ
Boston Scientific Strikes $615 Million Deal to Buy Medical Tech Firm Apollo Endosurgery	22-11-29	MT
Boston Scientific to Acquire Apollo Endosurgery for $615 Million; Apollo Shares Jump	22-11-29	MT
Boston Scientific to buy Apollo Endosurgery for $417 million	22-11-29	RE
Boston Scientific to Buy Apollo Endosurgery	22-11-29	DJ
Boston Scientific to acquire Apollo Endosurgery in $615 mln deal	22-11-29	RE
Boston Scientific Corporation entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. from a group of shareholders for approximately $500 million.	22-11-28	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-01	CI
Apollo Endosurgery, Inc. Raises Revenue Guidance for the Fiscal Year 2022	22-11-01	CI
Apollo Endosurgery, Inc. Enters into Third Amendment to the Lease	22-10-06	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
Apollo Endosurgery, Inc. Reiterates Revenue Guidance for the Fiscal Year 2022	22-08-02	CI
Apollo Endosurgery Says FDA Awards De Novo Marketing Authorization for 4 Weight-Loss Devices; Shares Rise Pre-Bell	22-07-13	MT
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity	22-07-13	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-03	CI
Apollo Endosurgery, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22	CI
Apollo Endosurgery, Inc. Provides Revenue Guidance for the Full Year 2022	22-02-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Apollo Endosurgery, Inc.

Equities

APEN

US03767D1081

Highlights

Filters